Arvinas (ARVN) Tax Provisions (2022 - 2026)
Arvinas (ARVN) recorded quarterly Tax Provisions of $100000.0 in Q1 2026, down 50.0% quarter-over-quarter from $200000.0 in Q4 2025, and down 50.0% on a YoY basis from $200000.0 in Q1 2025.
Arvinas (ARVN) Tax Provisions (2022 - 2026) Analysis & Trends
Arvinas' Tax Provisions history runs 5 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 50.0% year-over-year to $100000.0; the TTM figure through Mar 2026 stood at $300000.0 (down 50.0% YoY), while the FY2025 annual figure was $300000.0, down 50.0% from the prior year.
- Tax Provisions was $100000.0 for Q1 2026 at Arvinas, down from $200000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $10.8 million in Q4 2022 to a low of -$400000.0 in Q1 2023.
- Historically, Tax Provisions has averaged $1.4 million across 5 years, with a median of $200000.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions surged 166.67% in 2024, then slumped 250.0% in 2025.
- A 5-year view of Tax Provisions shows it stood at $10.8 million in 2022, then sank by 85.19% to $1.6 million in 2023, then plunged by 125.0% to -$400000.0 in 2024, then jumped by 150.0% to $200000.0 in 2025, then tumbled by 50.0% to $100000.0 in 2026.
- The last three Tax Provisions figures came in at $100000.0 (Q1 2026), $200000.0 (Q4 2025), and $300000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | -300,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | -400,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 1.60 Mn |
| Jun 30, 2023 | -300,000.00 |
| Mar 31, 2023 | -400,000.00 |
| Dec 31, 2022 | 10.80 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 3.40 Mn |
| Mar 31, 2022 | 4.50 Mn |